NEW YORK (GenomeWeb News) — Elan Pharmaceuticals has licensed GeneGo’s MetaCore suite, GeneGo said Tuesday. Elan plans to use the software and data suite in its neurology and autoimmune programs.
 
“MetaCore has substantial knowledge content coverage in the areas of CNS and autoimmune diseases, which the Elan scientists can leverage in their innovative research,” said Julie Bryant, GeneGo's vice president of business development, in a statement.
 
Financial terms of the deal were not released.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.